Fundraising Fox

Applied StemCell

Milpitas, US · Delaware corporation · 1 known investors

Leading CRO/CDMO specializing in cell and gene therapy with proprietary TARGATT genome editing and iPSC platform

Founders & leadership

RJ
Ruhong JiangExecutive Officer, Director
ZX
Zhenyu XiaoDirector
GY
Guoliang YuDirector

Investors · 1

Reported raises · per SEC filings

Form D private placements
$19MraisedOct 2016 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ruhong JiangExecutive Officer, Director
  • Zhenyu XiaoDirector
  • Guoliang YuDirector
Offering amount
$19M
Amount sold
$19M
Minimum investment
$1
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.